Addie DD, Dennis JM, Toth S, Callanan JJ, Reid S, Jarrett O (2000). Long-term impact on
a closed household of pet cats of natural infection with feline coronavirus, feline
leukaemia virus and feline immunodeficiency virus. Veterinary Record. 146 419-424
Arai M, Darman J, Lewis A, Yamamoto JK. (2000). The use of human hematopoietic
growth factors (rhGM-CSF and rhEPO) as a supportive therapy for FIV-infected cats.
Vet Immunol Immunopathol. 77(1-2):71-92.
Bachmann MH, Mathiason-Dubard C, Learn GH, Rodrigo AG, Sodora DL, Mazzetti P,
Hoover EA, Mullins JI (1997). Genetic diversity of feline immunodeficiency virus:
dual infection, recombination and distinct evolutionary rates among envelope
sequence clades. J Virol 74:4241-4253.
Barr MC, Zou LL, Long F, Hoose WA, Avery RJ (1997). Proviral organization and sequence
analysis of feline immunodeficiency virus isolated from a pallas cat. Virology
228:84-91.
Beatty JA, Willett BJ, Gault EA, Jarrett O (1996). A longitudinal study of feline
immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected
cats, using antigen-specific induction. J.Virol. 70:6199-6206.
Bienzle D, Reggeti F, Wen X, Little S, Hobson J, Kruth S (2004). The variability of
serological and molecular diagnosis of feline immunodeficiency virus infection.
Canadian Vet J 45:753-757.
Brown A, Bennett M, Gaskell CJ (1989). Fatal poxvirus infection in association with FIV
infection. Vet Rec.124(1):19-20
Brown EW, Yuhki N, Packer C, O’Brien SJ (1994). A lion lentivirus related to feline
immunodeficiency virus - epidemiologic and phylogenetic aspects. J. Virol.
68:5953-5968.
Callanan JJ, Jones BA, Irvine J, Willett BJ, McCandlish IA, Jarrett O (1996). Histologic
classification and immunophenotype of lymphosarcomas in cats with naturally and
experimentally acquired feline immunodeficiency virus infections. Vet
Pathol.33(3):264-72.
Carpenter MA, EW Brown, M Culver, WE Johnson, J Pecon-Slattery, D Brousset, SJ
O'Brien (1996). Genetic and phylogenetic divergence of feline immunodeficiency
virus in the puma (Puma concolor). J. Virol. 70:6682-6693
Crawford PC, Slater MR, Levy JK (2005). Accuracy of polymerase chain reaction assays
for diagnosis of feline immunodeficiency virus infection in cats. J Am Vet Med
Assoc;226(9):1503-7.
Crawford PC, Levy JK. 2007. New challenges for the diagnosis of feline immunodeficiency
virus infection. Vet Clin North Am Small Anim Pract. 37(2):335-50.
Dandekar S, Beebe AM, Barlough J Phillips T, Elder J, Torten M, Pedersen N (1992).
Detection of feline immunodeficiency virus (FIV) nucleic-acids in FIV-seronegative
cats. J. Virol. 66:4040-4049.
del Fierro GM, Meers J, Thomas J, Chadwick B, Park HS, Robinson WF (1995).
Quantification of lymphadenopathy in experimentally induced feline
immunodeficiency virus infection in domestic cats. Vet Immunol Immunopathol.
46(1-2):3-12.
de Mari K, Maynard L, Sanquer A, Lebreux B, Eun HM (2004). Therapeutic effects of
recombinant feline interferon-omega on feline leukemia virus (FeLV)-infected and
FeLV/feline immunodeficiency virus (FIV)-coinfected symptomatic cats. J Vet Intern
Med18(4):477-82.
Dunham SP, Bruce J, MacKay S, Golder M, Jarrett O. Neil JC (2006). Limited efficacy of
an inactivated feline immunodeficiency virus vaccine Vet Rec 158:561-562.
Egberink HF, De Clercq E, Van Vliet al. Balzarini J, Bridger GJ, Henson G, Horzinek MC,
Schols D (1999). Bicyclams, selective antagonists of the human chemokine receptor
CXCR4, potently inhibit feline immunodeficiency virus replication. J Virol 73:6346-
6352.
Fevereiro M, Roneker C, Laufs A, Tavares L, de Noronha F (1991). Characterization of
two monoclonal antibodies against feline immunodeficiency virus gag gene products
and their application in an assay to evaluate neutralizing antibody activity.
J.Gen.Virol. 72 (Pt 3):617-622.
Flynn JN, Dunham S, Mueller A, Cannon C, Jarrett O (2002). Involvement of cytolytic and
non-cytolytic T cells in the control of FIV infection. Vet Immunol Immunopathol
85:159-170.
Frey SC, Hoover EA, Mullins JI (2001). Feline immunodeficiency virus cell entry. J Virol
75:5433-5440.
George JW, Pedersen NC, Higgins J (1993). The effect of age on the course of
experimental feline immunodeficiency virus infection in cats. AIDS Res Hum
Retroviruses;9(9):897-905.
Hartmann K, Donath A, Kraft W (1995). AZT in the treatment of feline immunodeficiency
virus infection. Part 2. Fel Pract; 6: 13-20.
Hartmann K (1998). Feline immunodeficiency virus infection: an overview. Vet J
155:123-137.
Hartmann K, Stengel S, Klein D, Egberink H, Balzarini J (2002). Efficacy of the
chemokine receptor inhibitor 1,1’-bis-1,4,8,11-tetraazacyclotetradekan against
feline immunodeficiency virus infection. Abstract, 6th International Feline Retrovirus
Research Symposium. Amelia Island, USA, 2002: 26.
Hohdatsu T, Pu R, Torres BA, Trujillo S, Gardner MB, Yamamoto JK. (1993). Passive
antibody protection of cats against feline immunodeficiency virus infection. J Virol.
67(4):2344-8.
Hosie MJ, Robertson C, Jarrett O (1989). Prevalence of feline leukaemia virus and
antibodies to feline immunodeficiency virus in cats in the United Kingdom. Vet. Rec.
125:293-297.
Hosie MJ and Jarrett O (1990). Serological responses of cats to feline immunodeficiency
virus. AIDS 4:215-220.
Hosie MJ and Beatty JA (2007). Vaccine protection against feline immunodeficiency virus
–setting the challenge. Aus. Vet. J. 85: 5-12.
Hughes MS, Ball NW, Love DN, Canfield PJ, Wigney DI, Dawson D, Davis PE, Malik R
(1999). Disseminated Mycobacterium genavense infection in a FIV-positive cat. J
Feline Med Surg. 1(1):23-9.
Hutson CA, Rideout BA, Pedersen NC (1991). Neoplasia associated with feline
immunodeficiency virus infection in cats of southern California. J Am Vet Med
Assoc. 199(10):1357-62.
Ishida T, Taniguchi A, Matsumura S, Washizu T, Tomoda I (1992). Long-term clinical
observations on feline immunodeficiency virus infected asymptomatic carriers. Vet
Immunol Immunopathol 35(1-2):15-22.
Jordan HL, Howard J, Barr MC, Kennedy-Stoskopf S, Levy JK, Tompkins WA (1998).
Feline immunodeficiency virus is shed in semen from experimentally and naturally
infected cats. AIDS Res.Hum.Retroviruses 14:1087-1092.
Kakinuma S, Motokawa K, Hohdatsu T, Yamamoto JK, Koyama H, Hashimoto H (1995).
Nucleotide sequence of feline immunodeficiency virus: classification of Japanese
isolates into two subtypes which are distinct from non-Japanese subtypes. J Virol
69:3639-3646.
Kann RK, Kyaw-Tanner MT, Seddon JM, Lehrbach PR, Zwijnenberg RJ, Meers J (2006).
Molecular subtyping of feline immunodeficiency virus from domestic cats in
Australia. Aust Vet J 84:112-116.
Kennedy JM, Hoke A, Zhu Y, Johnston JB, van Marle G, Silva C, Zochodne DW, Power C
(2004). Peripheral neuropathy in lentivirus infection: evidence of inflammation and
axonal injury. AIDS;18(9):1241-50.
Levy J, Richards J, Edwards D, Elston T, Hartmann K, Rodan I, Thayer V, Tompkins M,
Wolf A (2003). 2001 Report of the American Association of Feline Practitioners and
Academy of Feline Medicine Advisory Panel on feline retrovirus testing and
management. J Feline Med Surg. 5(1):3-10.
Levy JK, Crawford PC, Slater MR (2004). Effect of vaccination against feline
immunodeficiency virus on results of serologic testing in cats. J Am Vet Med Assoc
225:1558-1561.
Lutz H, Arnold P, Hübscher U, Egberink H, Pedersen N.C, Horzinek MC (1988a).
Specificity Assessment of Feline T-lymphotropic Lentivirus Serology. Zbl. Vet. Med.
B, 35, 773-778
Lutz H, Egberink H, Arnold P, Winkler G, Wolfensberger C, Jarrett O, Parodi A.L, Pedersen
N.C, Horzinek MC (1988b). Felines T-lymphotropes Lentivirus (FTLV):
Experimentelle Infektion und Vorkommen in einigen Ländern Europas.
Kleintierpraxis 33, 455-459.
Lutz H, Lehmann R, Winkler G, Kottwitz B, Dittmer A, Wolfensberger C, Arnold P. (1990).
Das feline Immunschwächevirus in der Schweiz: Klinik und Epidemiologie im
Vergleich mit dem Leukämie- und dem Coronavirus. Schweiz.Arch.Tierheilk, 132,
217-225 (1990)
MacDonald K, Levy JK, Tucker SJ, Crawford. PC (2004). Effects of passive transfer of
immunity on results of diagnostic tests for antibodies against feline
immunodeficiency virus in kittens born to vaccinated queens. J Am Vet Med Assoc
225:1554-1557.
Masucci M, Gulotta L, Malara D, Perillo L, Pennisi MG (2006). Autoanticorpi sierici in corso
di infezione da FIV. Proceedings of Società Italiana delle Scienze Veterinarie, 60:
239-240.
Matsumoto H, Takemura N, Sako T, Koyama H, Motoyoshi S, Inada Y (1997). Serum
concentration of circulating immune complexes in cats infected with feline
immunodeficiency virus detected by immune adherence hemagglutination method.
J Vet Med Sci.59(5):395-6.
Miller RJ, Cairns S, Bridges S and Sarver, N (2000). Human immunodeficiency virus and
AIDS: insights from animal lentiviruses. J. Virol. 74:7187-7195
Moench TR, Whaley KJ, Mandrell TD, Bishop BD, Witt CJ, Cone RA (1993). The cat/feline
immunodeficiency virus model for transmucosal transmission of AIDS: nonoxynol-9
contraceptive jelly blocks transmission by an infected cell inoculum. AIDS 7:797-
802.
Olmsted RA, Hirsch VM, Purcell RH, Johnson PR (1989). Nucleotide sequence analysis of
feline immunodeficiency virus: genome organization and relationship to other
lentiviruses. Proc Natl Acad Sci USA 86:8088-8092.
Olmsted RA, Langley R, Roelke ME, Goeken RM, Adger-Johnson D, Goff JP, Albert JP,
Packer C, Laurenson MK, Caro TM, Scheepers L, Wildt DE, Bush M, Martenson JS
(1992). Worldwide prevalence of lentivirus infection in wild feline
species:Epidemiologic and phylogenetic aspects. J. Virol. 66:6008-6018.
O’Neil LL, Burkhard MJ, Diehl, LJ, Hoover EA (1995a). Vertical transmission of feline
immunodeficiency virus. Semin Vet Med Surg (Small Anim). 10(4):266-78.
O'Neil LL, Burkhard MJ, Diehl LJ, Hoover EA. (1995b). Vertical transmission of feline
immunodeficiency virus. AIDS Res Hum Retroviruses. 11(1):171-82.
O'Neil LL, Burkhard MJ, Hoover EA. (1996). Frequent perinatal transmission of feline
immunodeficiency virus by chronically infected cats. J Virol. 70(5):2894-901.
Pecoraro MR, Tomonaga K, Miyazawa T, Kawaguchi Y, Sugita S, Tohya Y, Kai C,
Etcheverrigaray ME, Mikami T (1996). Genetic diversity of Argentine isolates of
feline immunodeficiency virus. J Gen Virol.77 ( Pt 9):2031-5.
Pedersen NC, Ho EW, Brown ML, Yamamoto JK (1987). Isolation of a T-lymphotropic
virus from domestic cats with an immunodeficiency-like syndrome. Science
235:790-793.
Pedersen NC, Yamamoto JK, Ishida T, Hansen H (1989). Feline immunodeficiency virus
infection. Vet Immunol Immunopathol ;21(1):111-29. Review.
Pedersen NC, Leutenegger CM, Woo J, Higgins J (2001). Virulence differences between
two field isolates of feline immunodeficiency virus (FIV-APetaluma and FIVCPGammar)
in young adult specific pathogen free cats. Vet Immunol
Immunopathol.79(1-2):53-67.
Pedretti E, Passeri B, Amadori M, Isola P, Di Pede P, Telera A, Vescovini R, Quintavalla F,
Pistello M (2006). Low-dose interferon-alpha treatment for feline immunodeficiency
virus infection. Vet Immunol Immunopathol.;109(3-4):245-54.
Pennisi MG, Masucci M, De Majo M (1994). Presenza di anticorpi anti-nucleo in gatti FIV
positivi. Proceedings of Società Italiana delle Scienze Veterinarie, 48: 973-976.
Pennisi M.G., (2002). A high prevalence of feline leihmaniasis in southern Italy. In
Proceedings of the Second International Leishmaniasis Forum, Sevilla, Spain, 39-48
Phillips TR, Prospero-Garcia O, Wheeler DW, Wagaman PC, Lerner DL, Fox HS, Whalen
LR, Bloom FE, Elder JH, Henriksen SJ (1996). Neurologic dysfunctions caused by a
molecular clone of feline immunodeficiency virus, FIV-PPR. J Neurovirol.2(6):388-
96.
Phillips K, Arai M, Tanabe T, Raskin R, Volz M, Uhl EW, Yamamoto JK. (2005). FIVinfected
cats respond to short-term rHuG-CSF treatment which results in anti-GCSF
neutralizing antibody production that inactivates drug activity. Vet Immunol
Immunopathol. 15;108(3-4):357-71.
Podell M, Hayes K, Oglesbee M, Mathes L (1997). Progressive encephalopathy associated
with CD4/CD8 inversion in adult FIV-infected cats. J Acquir Immune Defic Syndr
Hum Retrovirol.;15(5):332-40.
Poli A, Abramo F, Taccini E, Guidi G, Barsotti P, Bendinelli M, Malvaldi G (1993). Renal
involvement in feline immunodeficiency virus infection: a clinicopathological study.
Nephron 64(2):282-8.
Poli A, Abramo F, Matteucci D, Baldinotti F, Pistello M, Lombardi S, Barsotti P, Bendinelli
M (1995a). Renal involvement in feline immunodeficiency virus infection: p24
antigen detection, virus isolation and PCR analysis. Vet Immunol Immunopathol.
46(1-2):13-20.
Poli A, Falcone ML, Bigalli L, Massi C, Hofmann-Lehmann R, Lombardi S, Bendinelli M,
Lutz H (1995b). Circulating immune complexes and analysis of renal immune
deposits in feline immunodeficiency virus-infected cats. Clin Exp Immunol.
101(2):254-8.
Pu R, Okada S, Little ER, Xu B, Stoffs WV, Yamamoto JK (1995). Protection of neonatal
kittens against feline immunodeficiency virus infection with passive maternal
antiviral antibodies. AIDS 9; 235-242.
Richards JR. 2005. Feline immunodeficiency virus vaccine: implications for diagnostic
testing and disease management. Biologicals. 33(4):215-7.
Richardson J, Pancino G, Merat R, Leste-Laserre T, Moraillon A, Schneider-Mergener J,
Alizon M, Sonigo P, Heveker N (1999). Shared usage of the chemokine receptor
CXCR4 by primary and laboratory-adapted strains of feline immunodeficiency virus.
J Virol 73:3661-3671.
Rimmelzwaan GF, Siebelink KH, Broos H, Drost GA, Weijer K, van Herwijnen R,
Osterhaus ADME (1994). Gag and env-specific serum antibodies in cats after
natural and experimental infection with feline immunodeficiency virus. Vet.
Microbiol. 39:153-165.
Ryan G, Grimes T, Brankin B, Mabruk MJ, Hosie MJ, Jarrett O, Callanan JJ (2005).
Neuropathology associated with feline immunodeficiency virus infection highlights
prominent lymphocyte trafficking through both the blood-brain and blood-choroid
plexus barriers. J Neurovirol. 11(4):337-45.
Schubach TM, Schubach A, Okamoto T, Pellon IV, Fialho-Monteiro PC, Reis RS, Barros
MB, Andrade-Perez M, Wanke B (2003). Haematogenous spread of Sporothrix
schenckii in cats with naturally acquired sporotrichosis. J Small Anim
Pract.44(9):395-8.
Shelton GH, Grant CK, Linenberg ML, Abkowitz JL (1990). Severe neutropenia associated
with griseofulvin in cats with FIV infection. J Vet Int Med 4(6) 317-9.
Shimojima M, Miyazawa T, Ikeda Y McMonagle EL, Haining H, Akashi H, Takeuchi Y,
Hosie MJ, Willett BJ (2004). Use of CD134 as a primary receptor by the feline
immunodeficiency virus. Science 303:1192-1195.
Siebelink KH, Tijhaar E, Huisman RC, Huisman W, de Ronde A, Darby IH, Francis MJ,
Rimmelzwaan GF, Osterhaus AD. (1995). Enhancement of feline immunodeficiency
virus infection after immunization with envelope glycoprotein subunit vaccines. J
Virol. 69(6):3704-11.
Sodora DL, Schpaer EG, Kitchell BE, Dow SW, Hoover EA, Mullins JI (1994). Identification
of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of
the FIV and human immunodeficiency virus type 1 evolutionary patterns. J Virol
68:2230-2238.
Tenorio AP, Franti CE, Madewell BR, Pedersen NC (1991). Chronic oral infections of cats
and their relationship to persistent oral carriage of feline calici-, immunodeficiency,
or leukemia viruses. Vet Immunol Immunopathol. 29(1-2):1-14.
Tompkins WA (1999). Immunomodulation and therapeutic effects of the oral use of
interferon-alpha: mechanism of action. J Interferon Cytokine Res. 19(8):817-28.
Torten M, Franchini M, Barlough JE, George JW, Mozes E, Lutz H, Pedersen NC (1991).
Progressive immune dysfunction in cats experimentally infected with feline
immunodeficiency virus. J Virol. 65(5):2225-30
Weaver CC, Burgess SC, Nelson PD, Wilkinson M, Ryan PL, Nail CA, Kelly-Quagliana KA,
May ML, Reeves RK, Boyle CR, Coats KS (2005). Placental immunopathology and
pregnancy failure in the FIV-infected cat. Placenta 26(2-3):138-47.
Willett BJ, Hosie MJ, Callanan JJ, Neil JC, Jarrett O (1993). Infection with feline
immunodeficiency virus is followed by the rapid expansion of a CD8+ lymphocyte
subset. Immunology 78:1-6.
Willett BJ, Hosie MJ, Neil JC, Turner JD, Hoxie JA 1997. Common mechanism of infection
by lentiviruses. Nature 385:587
Willett BJ, McMonagle EL, Ridha S, Hosie MJ (2006). Differential utilization of CD134 as a
functional receptor by diverse strains of feline immunodeficiency virus. J Virol
80:3386-3394.
Woo JC, Dean GA, Lavoy A, Clark R, Moore PF. (1999). Investigation of recombinant
human insulin-like growth factor type I in thymus regeneration in the acute stage
of experimental FIV infection in juvenile cats. AIDS Res Hum Retroviruses.
15(15):1377-88.
Yamamoto JK, Hansen H, Ho EW, Morishita TY, Okuda T, Sawa TR, Nakamura RM,
Pedersen NC (1989). Epidemiologic and clinical aspects of feline immunodeficiency
virus infection in cats from the Continental United States and Canada and possible
mode of transmission. J Am Vet Med Assoc 194 (2):213-220.
Zeidner NS, Myles MH, Mathiason-DuBard CK, Dreitz MJ, Mullins JI, Hoover EA (1990).
Alpha interferon (2b) in combination with zidovudine for the treatment of
presymptomatic feline leukemia virus-induced immunodeficiency syndrome.
Antimicrob Agents Chemother. 34(9):1749-56.